Last updated on February 2018

Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

Brief description of study

The FANTOM II trial is intended to assess safety and performance of the Fantom Bioresorbable Coronary Scaffold in native coronary arteries.

Clinical Study Identifier: NCT02539966

Find a site near you

Start Over


Copenhagen, Denmark
  Connect »

Erasmus Medical Center

Rotterdam, Netherlands
  Connect »